Your browser doesn't support javascript.
loading
Long-term expanding human airway organoids for disease modeling.
Sachs, Norman; Papaspyropoulos, Angelos; Zomer-van Ommen, Domenique D; Heo, Inha; Böttinger, Lena; Klay, Dymph; Weeber, Fleur; Huelsz-Prince, Guizela; Iakobachvili, Nino; Amatngalim, Gimano D; de Ligt, Joep; van Hoeck, Arne; Proost, Natalie; Viveen, Marco C; Lyubimova, Anna; Teeven, Luc; Derakhshan, Sepideh; Korving, Jeroen; Begthel, Harry; Dekkers, Johanna F; Kumawat, Kuldeep; Ramos, Emilio; van Oosterhout, Matthijs Fm; Offerhaus, G Johan; Wiener, Dominique J; Olimpio, Eduardo P; Dijkstra, Krijn K; Smit, Egbert F; van der Linden, Maarten; Jaksani, Sridevi; van de Ven, Marieke; Jonkers, Jos; Rios, Anne C; Voest, Emile E; van Moorsel, Coline Hm; van der Ent, Cornelis K; Cuppen, Edwin; van Oudenaarden, Alexander; Coenjaerts, Frank E; Meyaard, Linde; Bont, Louis J; Peters, Peter J; Tans, Sander J; van Zon, Jeroen S; Boj, Sylvia F; Vries, Robert G; Beekman, Jeffrey M; Clevers, Hans.
Afiliação
  • Sachs N; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Papaspyropoulos A; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Zomer-van Ommen DD; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Heo I; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Böttinger L; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Klay D; St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • Weeber F; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Huelsz-Prince G; FOM Institute AMOLF, Amsterdam, The Netherlands.
  • Iakobachvili N; Maastricht University, Maastricht, The Netherlands.
  • Amatngalim GD; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • de Ligt J; UMC Utrecht, Utrecht, The Netherlands.
  • van Hoeck A; UMC Utrecht, Utrecht, The Netherlands.
  • Proost N; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Viveen MC; UMC Utrecht, Utrecht, The Netherlands.
  • Lyubimova A; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Teeven L; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Derakhshan S; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Korving J; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Begthel H; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Dekkers JF; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Kumawat K; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Ramos E; Hubrecht Organoid Technology, Utrecht, The Netherlands.
  • van Oosterhout MF; St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • Offerhaus GJ; UMC Utrecht, Utrecht, The Netherlands.
  • Wiener DJ; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Olimpio EP; FOM Institute AMOLF, Amsterdam, The Netherlands.
  • Dijkstra KK; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Smit EF; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van der Linden M; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Jaksani S; Hubrecht Organoid Technology, Utrecht, The Netherlands.
  • van de Ven M; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Jonkers J; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Voest EE; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Moorsel CH; St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • van der Ent CK; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Cuppen E; UMC Utrecht, Utrecht, The Netherlands.
  • van Oudenaarden A; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands.
  • Coenjaerts FE; UMC Utrecht, Utrecht, The Netherlands.
  • Meyaard L; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Bont LJ; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Peters PJ; Maastricht University, Maastricht, The Netherlands.
  • Tans SJ; FOM Institute AMOLF, Amsterdam, The Netherlands.
  • van Zon JS; FOM Institute AMOLF, Amsterdam, The Netherlands.
  • Boj SF; Hubrecht Organoid Technology, Utrecht, The Netherlands.
  • Vries RG; Hubrecht Organoid Technology, Utrecht, The Netherlands.
  • Beekman JM; Wilhelmina Children's Hospital and UMC Utrecht, Utrecht, The Netherlands.
  • Clevers H; Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands h.clevers@hubrecht.eu.
EMBO J ; 38(4)2019 02 15.
Article em En | MEDLINE | ID: mdl-30643021
ABSTRACT
Organoids are self-organizing 3D structures grown from stem cells that recapitulate essential aspects of organ structure and function. Here, we describe a method to establish long-term-expanding human airway organoids from broncho-alveolar resections or lavage material. The pseudostratified airway organoids consist of basal cells, functional multi-ciliated cells, mucus-producing secretory cells, and CC10-secreting club cells. Airway organoids derived from cystic fibrosis (CF) patients allow assessment of CFTR function in an organoid swelling assay. Organoids established from lung cancer resections and metastasis biopsies retain tumor histopathology as well as cancer gene mutations and are amenable to drug screening. Respiratory syncytial virus (RSV) infection recapitulates central disease features, dramatically increases organoid cell motility via the non-structural viral NS2 protein, and preferentially recruits neutrophils upon co-culturing. We conclude that human airway organoids represent versatile models for the in vitro study of hereditary, malignant, and infectious pulmonary disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Técnicas de Cultura de Órgãos / Sistema Respiratório / Organoides / Infecções por Vírus Respiratório Sincicial / Carcinoma Pulmonar de Células não Pequenas / Fibrose Cística / Células Epiteliais Limite: Animals / Female / Humans / Male Idioma: En Revista: EMBO J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Técnicas de Cultura de Órgãos / Sistema Respiratório / Organoides / Infecções por Vírus Respiratório Sincicial / Carcinoma Pulmonar de Células não Pequenas / Fibrose Cística / Células Epiteliais Limite: Animals / Female / Humans / Male Idioma: En Revista: EMBO J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda